Interferon

Idenix Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of drugs for the treatment of human viral and other infectious diseases. The company developed Tyzeka/Sebivo through a co development agreement with Novartis Pharma AG for the treatment of patients with chronic hepatitis B in the United States and European Union for the treatment of patients with chronic hepatitis B.